Show Summary Details
Page of

Under-representation of older people in clinical trials 

Under-representation of older people in clinical trials
Under-representation of older people in clinical trials

Gary H. Mills

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 September 2021

Key points

Older people, often with high levels of co-morbidity and polypharmacy, are increasing in number as the population ages.

Study populations in clinical trials have often not mirrored the population that will consume the drugs or treatments being investigated.

Regulators, ethics committees, and funding bodies must recognize the need for inclusion of older people and the complexities this imposes on investigators.

Across all aspects of medicine, funding for research into how best to safely include older people in clinical trials is vital.

Researchers should not be disadvantaged by designing studies to meet the needs of the age range of patients expected to receive the treatment being investigated; this should include provision for older people.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.